BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) colonization predicts later infection, with both host and pathogen determinants of invasive disease. METHODS: This nested case-control study evaluates predictors of MRSA bacteremia in an 8-intensive care unit (ICU) prospective adult cohort from 1 September 2003 through 30 April 2005 with active MRSA surveillance and collection of ICU, post-ICU, and readmission MRSA isolates. We selected MRSA carriers who did (cases) and those who did not (controls) develop MRSA bacteremia. Generating assembled genome sequences, we evaluated 30 MRSA genes potentially associated with virulence and invasion. Using multivariable Cox proportional hazards regression, we assessed the association of these genes with MRSA bacteremia, controlling for host risk factors. RESULTS: We collected 1578 MRSA isolates from 520 patients. We analyzed host and pathogen factors for 33 cases and 121 controls. Predictors of MRSA bacteremia included a diagnosis of cancer, presence of a central venous catheter, hyperglycemia (glucose level, >200 mg/dL), and infection with a MRSA strain carrying the gene for staphylococcal enterotoxin P (sep). Receipt of an anti-MRSA medication had a significant protective effect. CONCLUSIONS: In an analysis controlling for host factors, colonization with MRSA carrying sep increased the risk of MRSA bacteremia. Identification of risk-adjusted genetic determinants of virulence may help to improve prediction of invasive disease and suggest new targets for therapeutic intervention.
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) colonization predicts later infection, with both host and pathogen determinants of invasive disease. METHODS: This nested case-control study evaluates predictors of MRSA bacteremia in an 8-intensive care unit (ICU) prospective adult cohort from 1 September 2003 through 30 April 2005 with active MRSA surveillance and collection of ICU, post-ICU, and readmission MRSA isolates. We selected MRSA carriers who did (cases) and those who did not (controls) develop MRSA bacteremia. Generating assembled genome sequences, we evaluated 30 MRSA genes potentially associated with virulence and invasion. Using multivariable Cox proportional hazards regression, we assessed the association of these genes with MRSA bacteremia, controlling for host risk factors. RESULTS: We collected 1578 MRSA isolates from 520 patients. We analyzed host and pathogen factors for 33 cases and 121 controls. Predictors of MRSA bacteremia included a diagnosis of cancer, presence of a central venous catheter, hyperglycemia (glucose level, >200 mg/dL), and infection with a MRSA strain carrying the gene for staphylococcal enterotoxin P (sep). Receipt of an anti-MRSA medication had a significant protective effect. CONCLUSIONS: In an analysis controlling for host factors, colonization with MRSA carrying sep increased the risk of MRSA bacteremia. Identification of risk-adjusted genetic determinants of virulence may help to improve prediction of invasive disease and suggest new targets for therapeutic intervention.
Authors: Kevin P Blaine; Marion J Tuohy; Deborah Wilson; Gary W Procop; Daniel J Tisch; Nabin K Shrestha; Geraldine S Hall Journal: Diagn Microbiol Infect Dis Date: 2010-09 Impact factor: 2.803
Authors: Karsten Becker; Alexander W Friedrich; Gabriele Lubritz; Maria Weilert; Georg Peters; Christof Von Eiff Journal: J Clin Microbiol Date: 2003-04 Impact factor: 5.948
Authors: Willem J B van Wamel; Suzan H M Rooijakkers; Maartje Ruyken; Kok P M van Kessel; Jos A G van Strijp Journal: J Bacteriol Date: 2006-02 Impact factor: 3.490
Authors: Carla J C de Haas; Karin Ellen Veldkamp; Andreas Peschel; Floor Weerkamp; Willem J B Van Wamel; Erik C J M Heezius; Miriam J J G Poppelier; Kok P M Van Kessel; Jos A G van Strijp Journal: J Exp Med Date: 2004-03-01 Impact factor: 14.307
Authors: R San-Juan; D Pérez-Montarelo; E Viedma; A Lalueza; J Fortún; E Loza; M Pujol; C Ardanuy; I Morales; M de Cueto; E Resino-Foz; M A Morales-Cartagena; M Fernández-Ruiz; A Rico; M P Romero; M Fernández de Mera; F López-Medrano; M Á Orellana; J M Aguado; F Chaves Journal: Eur J Clin Microbiol Infect Dis Date: 2017-05-05 Impact factor: 3.267
Authors: Nicholas A Turner; Batu K Sharma-Kuinkel; Stacey A Maskarinec; Emily M Eichenberger; Pratik P Shah; Manuela Carugati; Thomas L Holland; Vance G Fowler Journal: Nat Rev Microbiol Date: 2019-04 Impact factor: 60.633
Authors: Shu-Hua Wang; Lisa Hines; Joany van Balen; José R Mediavilla; Xueliang Pan; Armando E Hoet; Barry N Kreiswirth; Preeti Pancholi; Kurt B Stevenson Journal: J Clin Microbiol Date: 2015-03-04 Impact factor: 5.948
Authors: Emilia A Bonar; Michal Bukowski; Marcin Hydzik; Urszula Jankowska; Sylwia Kedracka-Krok; Magdalena Groborz; Grzegorz Dubin; Viktoria Akkerboom; Jacek Miedzobrodzki; Artur J Sabat; Alexander W Friedrich; Benedykt Wladyka Journal: Front Cell Infect Microbiol Date: 2018-09-06 Impact factor: 5.293
Authors: Weronika M Ilczyszyn; Artur J Sabat; Viktoria Akkerboom; Anna Szkarlat; Joanna Klepacka; Iwona Sowa-Sierant; Barbara Wasik; Maja Kosecka-Strojek; Aneta Buda; Jacek Miedzobrodzki; Alexander W Friedrich Journal: PLoS One Date: 2016-03-18 Impact factor: 3.240
Authors: Lavanya Challagundla; Jinnethe Reyes; Iftekhar Rafiqullah; Daniel O Sordelli; Gabriela Echaniz-Aviles; Maria E Velazquez-Meza; Santiago Castillo-Ramírez; Nahuel Fittipaldi; Michael Feldgarden; Sinéad B Chapman; Michael S Calderwood; Lina P Carvajal; Sandra Rincon; Blake Hanson; Paul J Planet; Cesar A Arias; Lorena Diaz; D Ashley Robinson Journal: Front Microbiol Date: 2018-08-22 Impact factor: 5.640